Back to results
US 12,624,035 B2Granted
Compounds for targeted protein degradation
AssigneeAmphista Therapeutics Limited
InventorsDavid Mcgarry, Giles Albert Brown, Pauline Drouhin
Life of this patent
Estimating the term…
Abstract
This disclosure provides a compound of formula (III): or a pharmaceutically acceptable salt, solvate or derivative thereof, wherein the substituents are as defined herein. The disclosure also provides pharmaceutical compositions comprising said compounds and the use of said compounds in the treatment of diseases, e.g. cancer.
Claims2
A compound, or a pharmaceutically acceptable salt thereof, wherein the compound is:
Dependencies are inferred from the claim text.